Sign In
Buy ANIP
$75.23
+0.580 (+0.777%)
At Close: Jun 03, 2026
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET
06:50am, Wednesday, 09'th Apr 2025
PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2025 finan
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
10:46am, Monday, 07'th Apr 2025
Here is how ANI Pharmaceuticals (ANIP) and Galectin Therapeutics Inc. (GALT) have performed compared to their sector so far this year.
Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO
09:25am, Monday, 07'th Apr 2025
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Expand Energy, Avista & Contango are well-poised to gain.
Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?
09:45am, Thursday, 03'rd Apr 2025
Investors need to pay close attention to ANI Pharmaceuticals (ANIP) stock based on the movements in the options market lately.
5 Relative Price Strength Stocks to Navigate Today's Market
10:45am, Tuesday, 01'st Apr 2025
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
5 High Earnings Yield Value Picks to Counter Market Uncertainty
09:25am, Tuesday, 01'st Apr 2025
Unlock your portfolio value with high earnings yield stocks like ANI Pharma, Insteel, Pitney Bowes, IHS Holding and HighPeak Energy.
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
04:30pm, Monday, 31'st Mar 2025
PRINCETON, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer
5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio
09:15am, Tuesday, 25'th Mar 2025
Five mid-cap stocks have strong revenues and earnings growth potential for 2025. These are: EAT, MAT, CENX, SKYW, ANIP.
Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 24'th Mar 2025
ANI (ANIP) possesses solid growth attributes, which could help it handily outperform the market.
Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?
10:55am, Monday, 24'th Mar 2025
ANI Pharmaceuticals, Inc. (ANIP) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ANIP's 50-day simple moving average broke out above
Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet
10:55am, Monday, 24'th Mar 2025
The mean of analysts' price targets for ANI (ANIP) points to a 26.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
06:50am, Wednesday, 19'th Mar 2025
PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI's Nitazoxanide Tablets
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
06:50am, Tuesday, 18'th Mar 2025
BAUDETTE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the buyout of its 3.125% perpetual royalty oblig
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
06:50am, Friday, 14'th Mar 2025
BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expan
Relative Price Strength: A Smart Strategy Amid Market Turmoil
09:20am, Thursday, 13'th Mar 2025
OOMA, ANIP, MATX, VIRT and EVER are five stocks with explosive relative price strength.
